The Hol Picture

Our Insights on Real-World Evidence and Behavioral Health

Posts about:

clinical data

A person exploring beneath the surface to extract hidden value

What is data density?

Innovation in behavioral health has long been limited by a lack of available data to support evidence-based decision-making. This lack of data can be attributed to many factors. Some of these factors are impossible to change, such as the heterogeneity of how the same diagnosis presents differently from patient to patient. Others could be changed but not without cooperation across behavioral health stakeholders; for example, a lack of consensus regarding how to define patient improvement, in addition to which tools to use to measure improvement, has resulted in a lack of standardization unseen in other areas of health.

Read More
an illustration of two people facing each other across a divide, chaotic flotsam in the background

Data missingness or expectation misalignment? A look into a common critique of real-world data

As biopharmaceutical companies and regulatory bodies look toward adopting EHR-derived real-world data to complete studies more efficiently and affordably, one major concern that often arises is what has come to be known as “data missingness.”

Read More
a series of question marks and ideas represented as light bulbs

What questions can EHR data answer for biopharmaceutical teams?

The treatment of behavioral health conditions has historically been challenging. Despite the prevalent use of the DSM-V in clinical settings, clinicians lack a detailed and standardized vocabulary to discuss these conditions. This is due to a range of factors, from wide differences in disease presentation to stigma surrounding mental health conditions. The lack of standardized vocabulary has led to a subjective approach in treating these conditions, with each clinician relying on his or her own experience.

However, as more and more patients who are treated for behavioral health conditions are documented within an electronic health record (EHR) system, researchers now have a valuable tool for studying and improving the treatment of behavioral health conditions. By bringing together vast quantities of real-world data to understand how care and treatment are delivered in clinical practice, we can start building a set of standard definitions and objective measures for mental health conditions.

This is why we have created the NeuroBlu Database, in which we have extracted and organized EHR data from behavioral health clinics across the U.S. Our NeuroBlu data has thus far been leveraged by 5 of the top 15 biopharmaceutical companies with a behavioral health pipeline. These companies can benefit greatly from EHR-derived real-world data, particularly in the areas of research and development, medical affairs, and health economics and outcomes research (HEOR).

Read More

EHR Data Hold the Key to Improving and Accelerating Behavioral Health Research

This is an excerpt from a longer post that originally appeared on Going Digital: Behavioral Health Tech.

Real-world data (RWD) are becoming increasingly critical to clinical research. The FDA has put forth definitions surrounding RWD, as well as issued guidance around its use in research emphasizing the principle of data being “fit-for-purpose”—selecting the data needed to answer the question at hand. Meanwhile, stakeholders engaged in clinical development have increasingly recognized that RWD will enable them to conduct studies faster, at a lower cost, and often, with a more representative and diverse population.

However, not all RWD is fit-for-purpose—that is, captured and stored in such a way that the data is ready to address the question at hand. In order to move forward with using RWD in a way that is efficient and effective, we need to build a shared understanding of the different types of data within the broad umbrella that is RWD and make clear which type of RWD is fit-for-purpose for a specific question.

Read More